These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17056015)

  • 1. Antagonism of the insulinotropic action of first generation imidazolines by openers of K(ATP) channels.
    Wienbergen A; Bleck C; Lackmann TG; Rustenbeck I
    Biochem Pharmacol; 2007 Jan; 73(1):94-102. PubMed ID: 17056015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
    Rustenbeck I; Dickel C; Grimmsmanns T
    Biochem Pharmacol; 2001 Dec; 62(12):1695-703. PubMed ID: 11755123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
    Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels.
    Szollosi A; Nenquin M; Henquin JC
    Br J Pharmacol; 2010 Feb; 159(3):669-77. PubMed ID: 20128805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
    Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
    Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous characteristics of imidazoline-induced insulin secretion.
    Rustenbeck I; Leupolt L; Kowalewski R; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):235-42. PubMed ID: 10208311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studies.
    Rustenbeck I; Winkler M; Jörns A
    Biochem Pharmacol; 2001 Dec; 62(12):1685-94. PubMed ID: 11755122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazoxide-sensitivity of the adenosine 5'-triphosphate-dependent K+ channel in mouse pancreatic beta-cells.
    Schwanstecher C; Dickel C; Ebers I; Lins S; Zünkler BJ; Panten U
    Br J Pharmacol; 1992 Sep; 107(1):87-94. PubMed ID: 1422580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetes; 2004 Dec; 53 Suppl 3():S135-9. PubMed ID: 15561901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cell toxicity of ATP-sensitive K+ channel-blocking insulin secretagogues.
    Rustenbeck I; Krautheim A; Jörns A; Steinfelder HJ
    Biochem Pharmacol; 2004 May; 67(9):1733-41. PubMed ID: 15081872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of mechanisms that account for imidazoline-induced lowering of blood glucose in mice.
    Stadlbauer K; Lehner Z; Stamenkovic N; Rustenbeck I; Surman L; Luger A; Fürnsinn C
    Eur J Pharmacol; 2014 Oct; 741():178-85. PubMed ID: 25149664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
    Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
    Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line.
    Dunne MJ; Illot MC; Peterson OH
    J Membr Biol; 1987; 99(3):215-24. PubMed ID: 2447283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
    Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
    Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
    Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of diazoxide and cromakalim with ATP-regulated K+ channels in rodent and clonal insulin-secreting cells.
    Jaggar JH; Harding EA; Ayton BJ; Dunne MJ
    J Mol Endocrinol; 1993 Feb; 10(1):59-70. PubMed ID: 8452640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
    Chan SL; Dunne MJ; Stillings MR; Morgan NG
    Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazoxide- and leptin-activated K(ATP) currents exhibit differential sensitivity to englitazone and ciclazindol in the rat CRI-G1 insulin-secreting cell line.
    Harvey J; Ashford ML
    Br J Pharmacol; 1998 Aug; 124(7):1557-65. PubMed ID: 9723971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulinotropic effect of fluoroquinolones.
    Ghaly H; Kriete C; Sahin S; Pflöger A; Holzgrabe U; Zünkler BJ; Rustenbeck I
    Biochem Pharmacol; 2009 Mar; 77(6):1040-52. PubMed ID: 19073153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.